Study Design. In-vivo ovine model of intervertebral disc degeneration (IVD) to evaluate treatment with stem cells. Objective. To determine if stem cells delivered to the nucleus pulposus (NP) or the annulus fibrosus (AF) of degenerated lumbar IVDs leads to improved indices of disc health. Summary of Background Data. Previous studies assessing the efficacy of stem cell injections into degenerated IVDs have reported positive findings. However, studies have been limited to small animals, targeting solely the NP, with short term follow-up. Methods. Mesenchymal precursor cells (MSC) were obtained from the iliac crest of 8-week-old sheep. IVD degeneration was induced by postero-lateral annulotomy at three lumbar levels in eight 2-year-old sheep. Six months later, each degenerated IVD was randomized to one of three treatments: Injection of MSC into (i) previously incised AF (AFI), (ii) NP (NPI), or (iii) no injection (negative control, NC). The adjacent IVD received injection of phosphate buffered saline into NP (positive control, PC). Radiographs and magnetic resonance imaging scans were obtained at baseline, 6, 9, and 12 months. Discs were harvested at 12 months for biochemical and histological analyses. Results. IVD degeneration was consistently observed postannulotomy, and characterized by reduced disc height index (DHI), disc height (DH), glycosaminoglycan (GAG) content, and increased grade of disc degeneration. Six months after stem cell injection, DHI and DH had recovered in AFI and NPI groups when compared with NC group (P < 0.01). Mean Pfirrmann grade improved from 3.25 to 2.67 (AFI group) and from 2.96 to 2.43 (NPI group). Mean histopathological grade improved for both AFI (P < 0.002) and NPI (P < 0.02) groups. Both AFI and NPI groups demonstrated spontaneous repair of the postero-lateral annular lesion. Conclusion. In this large animal model, injection of MSCs into the annulus fibrosus or the nucleus pulposus of degenerated IVD resulted in significant improvements in disc health.
L ow back pain (LBP) is the most common musculoskeletal condition affecting an individual's ability to work and manage activities of daily living. [1] [2] [3] It is estimated that nearly 60% of adults in the US report LBP episodes in the previous 3 months, making it the most common and most expensive physical ailment. [1] [2] [3] From 291 conditions identified in the 2010 Global Burden of Disease Study, 4 LBP ranked first as the leading cause of The lumbar intervertebral disc (IVD) is the largest avascular structure in the human body. Cells in the nucleus rely on the transport of solutes across the cartilaginous endplate. Sustained loading of the IVD has been shown to retard transport of small solutes into the center of the IVD. 8 Reduction in cellular nutrition is considered to be the final common pathway for disc degeneration. 9 Disc cell senescence and loss of cell viability inevitably lead to a decline in matrix integrity. 10 Age related reductions in proteoglycan and water content further compound the situation, with loss of disc height reducing the ability of the disc to distribute stresses evenly. As a result, endplate fractures, annular tears, and fissures may follow this uneven stress distribution. The growth of blood vessels and nerve fibres into such annular tears and fissures have been implicated as a major cause of chronic discogenic LBP. 11, 12 Spinal fusion for chronic discogenic LBP is invasive has mixed long-term results, and appears to have a little value over conservative measures such as physiotherapy and rehabilitation. There is increasing interest in cell therapy for DDD to repair and regenerate the IVD, in part stimulated by the success of cellular therapy for the treatment of articular cartilage defects. 13 There are a number of animal studies investigating the use of chondrocytes or mesenchymal precursor cells (MSC) injected into the nucleus pulposus (NP) to prevent height loss and promote disc regeneration [14] [15] [16] [17] [18] [19] [20] [21] Sakai et al 20 used a rabbit model with induced IVD degeneration to assess the efficacy of MSC injected into the NP. Overall IVD structure, cell volume, and matrix formation (in particular proteoglycan content) were maintained at 8 weeks after injection. Other studies utilizing MSCs in small animals have demonstrated the ability of these cells to survive, differentiate towards disc cells, and produce matrix components including collagen II and proteoglycans. 22 Ghosh et al 15 reported regeneration of the extracellular matrix in enzymatically-degenerated discs of sheep after stem cell injections into the NP. A recent systematic review and meta-analysis of the efficacy of IVD regeneration with stem cells in preclinical animal models concluded that stem cells transplanted to the NP of the IVD decelerate or arrest the IVD degenerative process. 23 To the author's knowledge, there have been no reports on the regenerative potential of MSC injection directly into the annulus fibrosus for established DDD. The aim of this study was to compare the efficacy or otherwise of injecting allogeneic ovine MSCs into the annulus fibrosus (AF) or the nucleus pulposus (NP) to retard or reverse experimentally induced IVD degeneration in a large animal (ovine) model. The method utilized to induce disc degeneration was a previously reported precise postero-lateral annulotomy, which accurately resembles the pathological process observed in the human IVD. 24 Clinical imaging modalities (radiographs, MRI), histopathology (disc degeneration grade and evidence of poster-lateral annular repair), and disc biochemistry were used to assess the effect of MSC injection into the AF or NP on improving indices of disc health.
MATERIALS AND METHODS
This study was approved by the Animal Ethics Committee of SA Pathology/Central Adelaide Local Health Network (CALHN), Adelaide, South Australia.
Ovine MSC Isolation and Culture
Fresh bone marrow aspirates were obtained from the iliac crest of 8-week old Merino Wether sheep under general anesthesia to maximize donor cell viability. Bone marrow mononuclear cells were isolated by centrifugation of aspirates on a Lymphoprep density gradient (S.G. 1.077 g/mL) (Axis Shield or Nycomed, Oslo, Norway). 25 MSCs were isolated by magnetic cell sorting based on STRO-4 expression, and then culture expanded to passage P5 as previously described.
26,27
Animal Protocol A further eight 2-year-old Merino Wether sheep (66.7þ /À4.7 kg) (equivalent human age ¼ 17-20 yrs old) were selected for the study. All radiographic imaging and operative procedures were carried out under general anesthesia. Each animal received 10 mg intravenous (IV) xylazine followed by 20 ml IV thiopentone. Animals were intubated and ventilated with 2% isoflurane and oxygen for the duration of the procedure.
Baseline lateral radiographs (T10 to sacrum, animal in lateral position) and magnetic resonance images (MRI) of the lumbar spine (supine) were obtained one day before each surgical intervention. Lateral radiographs were obtained with a mobile x-ray unit (KCD 12MC, Toshiba, Tochigi, Japan; x-ray energy 60 kV, current 2 mAs). The MR images were obtained using a 1.5T Siemens Magnetom Sonata MRI scanner (Siemens, Erlangen, Germany). T1 weighted (tse sag TR 450, TE 12), T2 weighted (tse sag (TR 3420, TE 92), and STIR sag (T1 130, TR 4840. TE 65) sequences were obtained in the midsagittal plane for all four time points.
Postero-lateral Annular Lesion (Time 0)
The lumbar spine was exposed via a direct lateral LEFT-side retroperitoneal approach. A precise postero-lateral annulotomy was made with number 15 scalpel blade directed transversely through the outer aspect of the posterior annulus toward the midline and inserted to the hilt on the scalpel blade as previously described 24 at three IVDs confirmed radiographically to be at L3/4, L4/5, and L5/6. Two tantalum beads were inserted into the adjacent vertebrae approximately 5 mm superior and inferior to the IVD to allow radiographic confirmation of the annulotomy sites. The wound was closed in layers. Postoperatively the animals received cephalexin (1 mL/kg IV), clavulox (1 mL/20 kg IM), and carprofen SC (50 mg/mL, 1 mL/25 kg). Each animal was recovered, kept in an air-conditioned indoor facility on a 12 hour light/dark cycle for 3 days and then transferred to an outdoor facility. The animals were kept in a paddock for 6 months to allow the postero-lateral annular lesion / IVD degeneration to mature.
MSC injection (Time R6 months)
Radiographs and MRI scans were repeated 27 weeks after the index surgery. In addition to the midsagittal cuts on MRI, axial cuts were performed at this time point through the three IVD that had previously received the annular lesion.
Immediately prior to MSC injection, frozen preparations of the MSCs were thawed at 378C and cell viability and number were assessed by trypan blue exclusion. 28 MSCs were labelled with cell-proliferation-labelling reagent bromodeoxyuridine (BrdU) 48 hours before intervertebral disc injection. 29 At 28 weeks (6 months) postsurgery, the three discs that received the postero-lateral annulotomy were randomly allocated to one of three treatments (see Table, Supplemental Digital Content 1, http://links.lww.com/BRS/ B123, which shows random allocation of treatments to degenerated and normal lumbar IVDs).
Injection of MSC [1 million allogeneic MSC/200 mL phosphate buffered saline (PBS)] into the previously incised annulus fibrosus (AFI; or into the nucleus pulposus (NPI); or no injection (negative control, NC). The nucleus pulposus of the superior adjacent (normal) lumbar IVD was injected with 200 mL PBS as a positive control (PC). For each injection a 19 gauge (1.1 mm) Â 38 mm needle and a 1 mL Luer-lock syringe was used. On this occasion, the lumbar spine was approached via a direct lateral right-sided retroperitoneal open approach to avoid any potential scar tissue from the previous left-sided surgery. Needle tip position was confirmed with fluoroscopy. Animals were returned to the paddock for an additional 3 months.
Subsequent Radiological Imaging (Time R9 months and Time R12 months)
All animals underwent repeat imaging with plain radiographs and MRI at two further time points (3 and 6 months respectively after MSC injection). At the latter time point, the animals were humanely killed with intravenous sodium pentobarbitone and the lumbar spinal column harvested for biochemical and histological analyses of each intervertebral disc.
Disc Height Index (DHI) by Radiographs
Digitized radiographs were used to determine the DHI using a previously published method 30 for all four time points, using two independent observers blinded to intervention group. Changes in DHI were expressed as %DHI and normalized to the measured preoperative IVD height.
Disc Height (DH) and Disc Degeneration (DD) grade by MRI
Midsagittal T 2 -weighted MR images were used to determine the disc heights by measurement of the anterior, middle, and posterior disc heights inside the cartilaginous endplate (h1, h2, h3, respectively (Figure 1 ). Digitized images were examined using the Sante DICOM Viewer programme (version 3.0.13, Sante DICOM Viewer, Santesoft LTD, Athens, Greece). The mean of the three regional values was taken as the mean disc height.
DD was classified according to a previously described ordinal scale (Pfirrmann et al 31 ) , which assigns grades based on changes in the intensity and homogeneity of the normally hyperintense white nucleus signal, and disc height (1¼ normal, 5 ¼ degenerated, Figure 2 ). DH and DD were assessed by three independent observers blinded to intervention group.
Biochemical Analysis
Immediately after harvest, each IVD was sectioned along the midsagittal plane using a low speed diamond-wheel saw (IsoMet, Buehler, Germany). The right segment was immediately frozen (-208C) for biochemical analysis; the left segment, which included the site of the previous annulotomy, was reserved for histological analysis (see below). For the biochemical analysis, the specimen was defrosted, the AF and NP were separated and weighed, then dried by SpeedVac (MiVac Quattro Concentrator, Genevac, UK) overnight at room temperature, and weighed again to calculate water content. The dried tissues were digested by papain overnight and an aliquot of the papain digest was used for assay with dimethyl methylene blue (DMMB, plate reader at 650 nm) 32 to determine sulphated glycosaminoglycan (GAG) content and with p-dimethyl-amino-benzaldehyde (DMAB) plate reader at 562 nm 33 to determine hydroxyproline (Hypro) content.
Histological Analysis and Histopathological Grading
The left segment of each IVD was fixed in 10% neutral buffered formalin for 10 days then immersed in 15% EDTA (solution changed weekly) until complete decalcification Figure 1 . Example of measurements (anterior h1, middle h2, and posterior h3, inside the cartilaginous endplate) used to determine intervertebral disc height from a midsagittal T2 weighted magnetic resonance image.
was confirmed by radiography. Two 4 mm thick slices were cut immediately adjacent to the midsagittal plane and in the parasagittal plane containing the annular lesion. These tissue slices were processed into paraffin; then 5 mmsections were cut and Haematoxylin & Eosin (H&E) stained. Two H&E sections from each of the midsagittal and parasagittal slices were graded by an experienced researcher (JSK), blinded to section identity, using a published IVD degeneration grading system (Gries et al 34 ). This system assigns a 4-point progressive degeneration grade (1 ¼ normal, 4 ¼ severe degeneration) to the nucleus pulposus, annulus fibrosus, cartilage end-plate, and margins/subchondral bone, with the overall IVD grade calculated as the mean of these subcompartment grades across the midsagittal and parasagittal sections.
The survival and localisation of injected MSCs was investigated by anti-BrdU antibody immunohistochemical staining of midsagittal and parasagittal paraffin sections (Cell Proliferation Kit, GE Healthcare, Buckinghamshire, UK). Positive control tissue was murine ectopic bone showing abundant BrdU-positive nuclear labelling of MSC-like cells 8 weeks posttransplantation. 29 Primary antibody was omitted for negative control immunostaining.
Statistical Analyses
All statistical analyses were completed using SAS 9.3 (SAS Institute Inc, Cary, NC). The data were analysed using linear mixed effects models with the animal as a random effect, and treatment and time as fixed effects. All tests were twotailed and significance was assessed at the 5% alpha level. To interpret the interaction of the fixed effects, the mean values for each treatment at each time point were plotted, and for the pair-wise comparisons between time-points for each treatment or between treatments for each time point, the mean differences and P values were tabulated. To meet the distributional assumptions of a linear mixed effects model, the biochemical data, and histopathological grade were first log transformed before analysis and then back transformed to the original scale before reporting. Thus, post hoc comparisons represent the ratio of two means, rather than the mean difference. All other data were normally distributed.
RESULTS
One animal became ataxic and stopped eating 6 weeks after index surgery (before MSC injections). The animal was treated with nonsteroidal antiinflammatory medication and intravenous antibiotics, but did not improve. The animal was humanely killed one week later, with a postmortem failing to identify significant pathology. The data for seven sheep are reported.
Intervertebral Disc Degeneration Model
All IVD were assessed 6 months after the postero-lateral annulotomy. These discs consistently demonstrated changes commensurate with established intervertebral disc degeneration including reduced DHI (radiograph), reduced disc height (MRI), and increased DD grade (MRI). 31 These changes were not observed in the PC discs (PBS injection only).
DHI by plain radiographs
There was a significant interaction between treatment and time for DHI (P < 0.0001). Before index surgery, no significant difference in DHI between treatment groups was observed (Figure 3a , see Supplemental Digital Content 2, http://links.lww.com/BRS/B123, which shows comparison of DHI at each time point within each treatment group). As expected, the negative control (NC) DHI was significantly reduced after annulotomy (P < 0.01, Figure 3a , see Supplemental Digital Content 2, http://links.lww.com/BRS/B123), At 6 months post annulotomy, the IVDs demonstrated a significant reduction in DHI (33%, P < 0.01). At 6 months post MSC injection, the DHI had recovered by 16% in the NPI group and 33% in the AFI group (P < 0.01).
At 6 months the PC (normal disc) had higher DHI than each of the other three treatments (P < 0.05). At 9 months post annulotomy, the DHI of the NPI and AFI was significantly higher than that of the NC, but lower than that of the PC group (P < 0.01).
At 12 months post annulotomy, the DHI of the NPI and AFI were significantly higher than that of the NC group, and not different from that of the PC (P < 0.05) indicating a degree of recovery in the NPI and AFI groups. There was no difference in DHI for the AFI and NPI at both 3 and 6 months post stem-cell injection.
DH by MRI
There was a significant interaction between treatment and time for DH (P < 0.05). The DH of NC (annulotomy alone) was significantly reduced at 6 months post annulotomy (P < 0.0001) (Figure 3b , Supplemental Digital Content 4, http://links.lww.com/BRS/B123, which shows comparison of DH (by MRI) at each time point within treatment group). For the PC (normal disc þ PBS), DH was reduced by only 3% at 6 months compared to baseline (P < 0.01) (Figure 3b , Supplemental Digital Content 4, http://links.lww.com/BRS/ B123) indicating that injection of PBS did not lead to reduction in DH. DH in the NPI and AFI groups increased by 18% and 22% respectively, in the 6 months after MSC injection (P < 0.02) (Supplemental Digital Content (SDC) 4 and 5, with SDC 5, http://links.lww.com/BRS/B123 showing comparison of DH (MRI) by treatment group within time point), indicating a degree of recovery in these treated discs.
Disc Degeneration by Pfirrmann Grade (1 to 5) on MRI Scan
For the PC (normal disc) there was no significant change in Pfirrmann Grade at 0, 6, 9, and 12 months. At 6 months, all IVDs that underwent postero-lateral annulotomy (NC, AFI, and NPI) increased disc degeneration from Grade 1 to Grade 3, with no significant differences between groups.
Six months after MSC injection, the mean disc degeneration grade for the AFI group improved from 3.25 to 2.67 (-0.58) and the NPI group improved from 2.96 to 2.43 (-0.43). However, the NC (annulotomy alone) also improved from 3.10 to 2.81 (-0.29).
Biochemistry
The GAG content (in dry tissue) was significantly higher for the PC group compared with the NC, AFI, and NPI groups, irrespective of the sampling region ( Figure 4 ). As expected, the nucleus pulposus region contained significantly more GAG (267.93 vs. 116.62 mg/mg dry matter, P < 0.0001) and water (69.62% vs. 55.02%, P < 0.0001) than the annulus fibrosus region for all treatment types. The hydroxyproline (in dry tissue) and water content of the IVDs were not different between treatment groups. There was no interaction between treatment and sampling region for water content, GAG, and hydroxyproline content.
Intervertebral Disc Histopathology
The mean histopathological grades for the treated (NPI and AFI) and control (NC and PC) IVD groups are shown in Figure 5 . The mean disc degeneration grade 34 for the NC (annulotomy only) group was significantly higher than that for the PC (normal disc) group (P < 0.0001), histologically confirming IVD degeneration 12 months post annulotomy (Figure 6a) .
Injection of MSC into the NP resulted in a significant improvement in mean histopathology grade when compared with the NC group (P < 0.02). The mean grade was significantly higher for the NPI group when compared with the PC group (P < 0.0005). MSC injection into the AF resulted in a similar improvement in mean histopathological grade versus the NC group (P < 0.002, Figure 6b) , with the AFI mean grade significantly higher than the PC group (P < 0.004). There was no difference in mean histopathology grade between the NPI and AFI groups ( Figure 5 ).
Parasagittal histology showed that spontaneous repair of the annular lesion to be minimal at 12 months post-annulotomy (Figure 7a ). MSC injection into either the AF or NP resulted in a hyper-proliferative and vascular reparative reaction at the lesion margins. The extent of AF-like collagenous tissue infilling of the lesion was more pronounced for AFI than NPI groups (Figure 7c and 7b, respectively) .
At 6-months post-MSC injection no BrdU-immunopositive cell nuclei were detected in midsagittal or parasagittal tissue sections for the NPI or AFI groups.
DISCUSSION
The current study demonstrated that postero-lateral annular lesions in the lumbar IVDs resulted in MRI-detectable established IVD degeneration at 6, 9, and 12 months. These MRI changes were confirmed at 12 months (end of study) by histology.
Injection of MSCs (1 million MSC/200 ml PBS) into the nucleus pulposus (NPI) or annulus fibrosis (AFI) of such degenerated IVDs resulted in partial recovery of DHI and DH when compared with the negative control (annulotomy alone). Notably, a similar improvement in disc height was observed irrespective of the site of MSC injection, with NPI and AFI groups showing an 18% and 22% increase respectively at 6 months.
The disc height and axial loading properties of the healthy spine can be attributed to water molecules binding tightly to proteoglycans present within the NP and inner AF.
The observed improvement in DHI and DH for the MSCinjected discs could not be attributed to changes in the proteoglycan or collagen or water composition of the NP or AF. However a limitation of the study was that the biochemical analysis was performed on IVD tissue contralateral to the side of the lesion, and thus matrix changes specific to the lesion site were not assessed. In an ovine model, it has previously been shown that the injection of mesenchymal precursor cells into the NP of chemicallydegenerated discs results in partial regeneration of the extracellular matrix of the disc. 15 However, the aforementioned study was limited to radiographic, MRI, and histopathological assessment of disc health. There were no biochemical measures of disc constituents, and the authors' conclusion was primarily derived from superficial observations of increased proteoglycan histochemical staining, data of which were not shown.
In the current study, the availability of parasagittal histology of the annular lesion revealed a qualitative improvement in cellular and matrix repair 6 months after MSC injection into the NP or AF when compared with spontaneous repair. Notably, collagenous tissue infilling of the lesion appeared to be more advanced for AFI than for NPI.
Previous studies show that MSCs can differentiate into chondrocyte and fibro-chondrocyte like cells capable of synthesizing proteoglycans. 19, 35 These proteoglycans would bind water molecules and result in elevation of disc height and increase stability of the IVD. Injected MSC that engraft may undergo such differentiation into chondrocytes or fibro-chondrocytes.
Our study investigated the fate of injected MSCs by labeling these with the cell proliferation marker BrdU before injection. BrdU is incorporated into newly synthesized DNA as a substitute for thymidine and thereby permanently labels proliferating and daughter cells until it is diluted out through multiple rounds of cell division. However, implanted MSC, which survive in vivo, generally do not undergo extensive proliferation as assessed by retention of BrdU over time. 36 BrdU is detected by immunostaining of tissue sections with an anti-BrdU primary antibody. Six months after MSC injection into the NP or AF there was no evidence of BrdU-immuno-positive cell nuclei in either the midsagittal or parasagittal tissue sections. Therefore, it appears that there is no survival of injected MSCs beyond 6 months. However, it is not known how many cell divisions the MSCs had undergone, and thus whether the presence of any BrdU-labeled cells was below the level of immunodetection. The finding of no BrdU-positive cells at 6 months postinjection precluded any further immunolocalization studies using phenotypic markers to investigate the differentiation and migratory fate of the MSCs.
Other possible mechanisms of improved disc height could be attributable to MSC anti-inflammatory properties (i.e., growth factors including members of the TGFs which suppress inflammation and ongoing disc degeneration). Release of trophic factors and anti-inflammatory cytokines by MSC 
